Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (SHE:300255)

SHE:300255 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 13, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	23,215	18,372	11,957	5,036	7,472	5,693
Market Cap Growth	70.02%	53.65%	137.41%	-32.59%	31.26%	11.92%
Enterprise Value	25,421	20,352	14,091	6,817	8,617	6,631
Last Close Price	25.26	19.99	13.01	5.47	8.09	6.15
PE Ratio	-	-	-	287.58	31.99	22.52
Forward PE	-	12.44	12.44	12.44	12.44	12.44
PS Ratio	22.52	17.82	8.48	2.16	2.52	2.41
PB Ratio	15.12	11.96	6.64	1.65	2.43	2.00
P/TBV Ratio	18.51	14.65	8.02	1.80	2.68	2.20
P/OCF Ratio	412.95	326.80	354.53	1611.41	2602.11	-
EV/Sales Ratio	24.10	19.74	9.99	2.92	2.90	2.81
EV/EBITDA Ratio	-	-	-	41.33	22.68	15.64
EV/EBIT Ratio	-	-	-	63.13	26.59	17.98
EV/FCF Ratio	-138.63	-	-	-	-	-
Debt / Equity Ratio	1.63	1.62	1.32	0.82	0.57	0.47
Debt / EBITDA Ratio	68.58	-	-	15.10	4.58	3.14
Asset Turnover	0.22	0.23	0.27	0.42	0.61	0.56
Inventory Turnover	0.57	0.57	0.85	0.56	0.60	0.45
Quick Ratio	0.25	0.23	0.29	0.72	0.52	0.67
Current Ratio	0.82	0.91	1.19	2.18	1.97	2.12
Return on Equity (ROE)	-12.23%	-15.83%	-51.43%	0.33%	7.81%	9.01%
Return on Assets (ROA)	-0.57%	-1.32%	-13.46%	1.20%	4.15%	5.41%
Return on Capital (ROIC)	-0.68%	-1.48%	-14.74%	1.30%	4.50%	5.94%
Return on Capital Employed (ROCE)	-	-	-	2.50%	9.40%	11.70%
Earnings Yield	-1.07%	-1.36%	-10.37%	0.35%	3.13%	4.44%
FCF Yield	-0.79%	-1.00%	-1.72%	-8.50%	-4.08%	-6.73%
Dividend Yield	-	-	-	0.09%	0.32%	-
Payout Ratio	-	-	-	708.02%	26.50%	27.08%
Buyback Yield / Dilution	-0.89%	-0.58%	-4.91%	6.27%	0.23%	0.24%
Total Shareholder Return	-0.89%	-0.58%	-4.91%	6.37%	0.55%	0.24%

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.